|
Gemcitabine Hydrochloride Clinical Trials
10 actively recruiting trials across 7 locations
▲ +1 trial since May 2026
Also known as: Difluorodeoxycytidine Hydrochloride, FF 10832, FF-10832, FF10832, Gemcitabine HCI +5 more
Pipeline
Phase 2: 6Phase 3: 3Phase 2/3: 1
Top Sponsors
- National Cancer Institute (NCI)4
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1
- Shanghai Junshi Bioscience Co., Ltd.1
- Ohio State University Comprehensive Cancer Center1
- Northwestern University1
Indications
- Cancer10
- Lung Cancer2
- Breast Cancer2
- Gallbladder Cancer Unresectable1
- Refractory Urothelial Carcinoma1
Other3 trials
Anchorage, Alaska1 trial
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Anchorage Associates in Radiation Medicine
Phase 3
Kingman, Arizona1 trial
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Kingman Regional Medical Center
Phase 2/3
Orange, California1 trial
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
UC Irvine Health/Chao Family Comprehensive Cancer Center
Phase 2
Chicago, Illinois1 trial
Bethesda, Maryland1 trial
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
National Cancer Institute Developmental Therapeutics Clinic
Phase 2
Mankato, Minnesota1 trial
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
Mayo Clinic Health Systems-Mankato
Phase 2
Columbus, Ohio1 trial
Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cystic Neoplasms
Ohio State University Comprehensive Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.